Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

This study has been completed.
Information provided by:
Valeant Pharmaceuticals International, Inc. Identifier:
First received: July 2, 2004
Last updated: May 3, 2007
Last verified: May 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Estimated Primary Completion Date: No date given